Pune, India

D Rajput Lalitkumar

This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D Rajput Lalitkumar. Retrieved from https://idiyas.com/inventor/d-rajput-lalitkumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: D Rajput Lalitkumar: Innovator in Pharmaceutical Chemistry

Introduction

D Rajput Lalitkumar is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work is characterized by a focus on creating commercially viable and reproducible methods.

Latest Patents

Lalitkumar holds a patent for the "Process for the preparation of pure and stable crystalline Raltegravir potassium form 3." This invention provides improved methods for producing pure and stable crystalline Raltegravir potassium Form 3, along with its pharmaceutical compositions. The patent highlights his commitment to advancing pharmaceutical formulations.

Career Highlights

Lalitkumar is associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and development. His contributions have been instrumental in enhancing the company's product offerings.

Collaborations

Some of his notable coworkers include B Shivdavkar Radhakrishna and Gaurav Amrut Patil. Their collaboration has likely fostered an environment of innovation and shared knowledge within the company.

Conclusion

D Rajput Lalitkumar's work exemplifies the impact of innovation in pharmaceutical chemistry. His patent for Raltegravir potassium Form 3 showcases his dedication to improving drug preparation processes. His contributions continue to influence the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…